Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
--------
Question: Paragraph: The state Department of Environmental Conservation says an investigation determined the geese died of the fungal disease Aspergillosis, caused by eating moldy grain or bread. Three dozen Canada geese were found dead in a pond at the Malone Recreation Park in Franklin County near the Canadian border. State wildlife staff in Albany tested the dead birds. The state agency is asking the public not to feed waterfowl to help prevent the fungal disease or cause poor nutrition, delayed migration and other problems. Officials are also asking farmers to dispose of moldy grain and silage by burying it rather than spreading it over fields. Claim: Moldy bread or grain blamed for Canada geese deaths.

Answer: Moldy bread or grain has been blamed for the death of dozens of Canada geese in an upstate New York park.


Question: Paragraph: Cuomo’s cautiously upbeat report at a daily briefing came as the daily death toll across the state, the epicenter of the pandemic in the United States, dropped to 540 on April 17, down from 630 a day earlier and the lowest in more than two weeks. The governor said total hospitalizations of patients being treated for COVID-19, the respiratory illness caused by the coronavirus, came to 16,967, a drop of more than 1,300 over the past three days. Intubations and admissions to intensive care units also continued on their downward trend. “If you look at the past three days, you could argue that we are past the plateau and we’re starting to descend which would be very good news,” Cuomo said. He said, however, that about 2,000 infected people were newly admitted to hospitals on Friday, which he characterized as “still an overwhelming number,” and reiterated that he would take a cautious approach to reopening businesses and schools. Cuomo repeated a call for the federal government to help coordinate and provide funding for the mass testing that he and other governors have said is needed to determine when it is safe for people to go back to work. Providing new details on the challenge, Cuomo said a survey of labs in his state revealed an inability to procure the chemical reagents needed to run the tests on machines supplied by private manufacturers like Roche Holding AG. “They bought the machine, they have the machine, they have the test, but they need the reagents to do a higher volume of tests,” Cuomo said, adding that makers like Roche are struggling to get the reagents from China. “That’s the logjam we are in.”  New York disclosed 7,090 new positive cases over the last 24 hours for a total of 236,732 cases, while deaths increased by 540 to 13,362, marking by far the largest number of fatalities of any state. Even with stabilizing numbers, Cuomo said the pandemic was taking a severe emotional and economic toll on people, and estimated the impact on society would prove to be the biggest challenge facing the country since World War Two. “On every level this is a terrible experience, Cuomo said. “It is as tumultuous a time as we have ever seen.” Claim: New York Governor sounds optimistic note as coronavirus numbers improve.

Answer: New York Governor Andrew Cuomo said on Saturday that a recent drop in hospitalizations and other improving metrics indicated the state may be past the peak of its coronavirus crisis and on a path toward stabilizing its battered healthcare system.


Question: Paragraph: “The two drugs work through different mechanisms of action,  but there is a synergistic effect that inhibits the growth of  prostate cancer cells,” said Xi Cheng, assistant research  professor at Rutgers, the State University of New Jersey, who  conducted the study. His team administered a combination of Celebrex, a  non-steroidal anti-inflammatory drug used to treat arthritis  and other pain, and Lipitor, a cholesterol lowering statin, to  cultured mice tumors in order to measure the transition of  early prostate cancer to its more aggressive and potentially  fatal stage. Both drugs are sold by Pfizer Inc, but the company played  no role in the National Institutes of Health-funded study,  Zheng said. The researcher said both drugs have been shown in earlier  studies to have some impact on cancer growth when used alone. The Rutgers team found that the combination of low doses of  Lipitor and Celebrex had a more potent impact on tumor growth  than a higher dose of either agent when used separately. Prostate cancer is the second-leading cause of cancer death  in men in the United States, with more than a quarter-million  new cases appearing each year, according to the American Cancer  Society. In the early stage of the disease, prostate cancer cells  depend on androgen hormones, such as testosterone, to grow. Treatment involves either decreasing the production of the  hormone or blocking its action. “Anti-androgen therapy slows the prostate cancer but  eventually the cancer becomes androgen-independent, the therapy  becomes ineffective and the cancer cells become more  aggressive,” said Zheng. “Treatments available for the later stage cancers are not  very good,” Allan Conney, director of cancer research at  Rutgers, said in a statement. “Oncologists employ classical  chemotherapy drugs which are very toxic and don’t work all that  well.”    The objective of the Rutgers study was to indefinitely  delay the transition to androgen-independence, prolonging the  time during which the cancer would be responsive to  low-toxicity, anti-hormone therapy. Zheng said it appears that a cell signaling pathway for  tumor cell growth is inhibited by the combination of the two  compounds. He said human clinical trials are being planned. Claim: Celebrex-Lipitor combo may fight prostate cancer.

Answer:
The combination of anti-inflammatory  and cholesterol-lowering drugs may be able to stop the  progression of prostate cancer, according to new research so  far carried out only in mice.